| Literature DB >> 29462895 |
Abstract
A new series of 2-amino-5-arylazothiazole derivatives has been designed and synthesized in 61-78% yields and screened as potential antibacterial drug candidates against the Gram negative bacterium Escherichia coli. The geometry of the title compounds were being studied using the Material Studio package and semi-core pseudopods calculations (dspp) were performed with the double numerica basis sets plus polarization functional (DNP) to predict the properties of materials using the hybrid FT/B3LYP method. Modeling calculations, especially the (EH-EL) difference and the energetic parameters revealed that some of the title compounds may be promising tools for further research work and the activity is structure dependent.Entities:
Keywords: 2-amino-4-phenylthiazole; 4-aminoacetophenone; DFT; antibacterial; benzoyl chloride; modeling
Mesh:
Substances:
Year: 2018 PMID: 29462895 PMCID: PMC6017174 DOI: 10.3390/molecules23020434
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Scheme 1Acetylation and benzoylation of 5-(4-acetylphenylazo)-2-amino-4-phenylthiazole (2).
Scheme 2Chloroacetylation of 5-(4-acetylphenylazo)-2-amino-4-phenylthiazole (2).
Scheme 3Diazocoupling of N-thiazolyl cyanoacetamide derivative 7 with aryl diazonium chlorides.
Figure 1The electron density, the HOMO and LUMO frontier orbitals of 5-(4-acetylphenylazo) thiazoles 2, 3, 4, 5 and 6.
Figure 2The electron density, the HOMO and LUMO frontier orbitals of N-(thiazol-2-yl)-2-arylhydrazono-2-cyanoacetamides 8a–e.
Calculated EHOMO, ELUMO, electronegativity (χ), chemical potential (μ), global hardness (η), global softness (S), global electrophilicity index (ω) and softness (σ) for thiazole derivatives complexes.
| Cpd. No. | Binding Energy | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| −4.718 | −3.128 | −1.590 | 3.923 | −3.923 | 0.795 | 0.629 | 9.679 | 1.258 | −4292.325 | |
| −4.493 | −2.916 | −1.577 | 3.704 | −3.704 | 0.788 | 0.634 | 8.702 | 1.268 | −4865.082 | |
| −4.872 | −3.287 | −1.585 | 4.079 | −4.079 | 0.792 | 0.631 | 10.499 | 1.262 | −5828.195 | |
| −4.938 | −3.353 | −1.585 | 4.145 | −4.145 | 0.792 | 0.631 | 10.842 | 1.262 | −4844.288 | |
| −4.885 | −3.317 | −1.568 | 4.101 | −4.101 | 0.784 | 0.638 | 10.726 | 1.275 | −6461.612 | |
| −4.684 | −2.857 | −1.827 | 3.771 | −3.771 | 0.913 | 0.547 | 7.781 | 1.095 | −4488.996 | |
| −5.147 | −3.809 | −1.338 | 4.478 | −4.478 | 0.669 | 0.747 | 14.987 | 1.495 | −4724.220 | |
| −5.127 | −3.78 | −1.347 | 4.453 | −4.453 | 0.6735 | 0.742 | 14.724 | 1.485 | −4725.903 | |
| −4.802 | −3.047 | −1.755 | 3.924 | −3.924 | 0.8775 | 0.569 | 8.7758 | 1.139 | −4618.547 | |
| −5.392 | −3.654 | −1.738 | 4.523 | −4.523 | 0.869 | 0.575 | 11.771 | 1.151 | −5491.744 |
Antibacterial activities expressed as inhibition diameter zones in millimeters (mm) of the tested compounds against Escherichia coli.
| Compound Number | ||
|---|---|---|
| Diameter of Inhibition Zone (in mm) | % Activity Index | |
| 8 | 33.3 | |
| 12 | 50.0 | |
| NA | ---- | |
| 15 | 62.5 | |
| 19 | 79.2 | |
| 16 | 66.7 | |
| 18 | 75.0 | |
| 14 | 58.3 | |
| 16 | 66.7 | |
| NA | ---- | |
| Ampicillin | 24 | 100 |
NA = No Activity.